This Week on NeurologyLive® — March 7, 2022

Put on in conjunction with Cure SMA, this NeurologyLive^® Cure Connections^® series, "The Identification and Evaluation of Suspected Spinal Muscular Atrophy (SMA) in Children and Adolescents During a Telehealth Appointment," features Crystal Proud, MD, and Craig Zaidman, MD, as they discuss the importance of SMA screening, diagnosis of SMA in children and adolescents through telehealth, and demonstrate the process of a real telehealth appointment with patients.

To catch up on the series, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, March 9. This week, it will feature a conversation with Jiwoh Oh, MD, PhD, staff neurologist, St Michaels Hospital, University of Toronto, about the clinical utility of imaging biomarkers of radiologically isolated syndrome and the MS prodrome.

To check out the prior NeuroVoices conversations, click here.

The MJH Life Sciences Medical World News streaming channel is always streaming 24/7, so make sure to check out the channel for new episodes, and catch up on-demand with your favorites before the new episodes go live—and now you can catch up on all new content from season 5!

This week, NeurologyLive^® contributed to Second Opinion, which features a conversation between Jurriaan Peters, MD, PhD, and Eric Segal, MD, about a case study of a child experiencing unexplained strange spells, and the various approaches to the situation.

To catch up and check out what's on the Medical World News channel now, or check out hundreds of episodes on-demand, click here.

The 59th episode of the NeurologyLive® Mind Moments™ podcast will premiere on Friday, March 11! The show will feature an exclusive conversation with Seema Khosla, MD, FCCP, FAASM, medical director, North Dakota Center for Sleep, who shared insight into the American Academy of Sleep Medicine's goal of moving away from daylight savings time and establishing a fixed standard time year-round, and the impact it can have on sleep, among other topics.

To listen and subscribe on your favorite podcast player, click here.

IN CASE YOU MISSED IT: The annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum took place Feb 24-26. The NeurologyLive^® team was on-site providing coverage straight from the conference floor, including in-depth conversations with experts and opinion leaders, as well as the latest on data readouts and sessions from the forum. Our coverage will continue into this week, so keep checking back for more!

To catch up on the coverage of ACTRIMS, click here.

IN CASE YOU MISSED IT: According to the National Institutes of Health’s clinical trials registry, more than 400 clinical trials of therapies designed to treat neurologic diseases are actively ongoing across phases 1 through 3 . Of those, more than 200 are in phase 3 development. Notably, many investigational therapies are addressing diseases with a high unmet clinical need, with either no currently available disease-modifying therapies or very limited options.

With so much activity in the clinical development pipeline, keeping up with the latest findings can sometimes be difficult. Here are 5 critical trials with expected data readouts in 2022 that NeurologyLive® will have its eye on.